Ritonavir film coated (ritonavir 100 mg) NDC 69097-655

NDC codes

FDA NDC Directory

Product NDC (as listed)69097-655Labeler and product segments. Claims need a package NDC.

Product NDC at billing width69097-0655Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
69097-655-02	69097065502	30 TABLET in 1 CONTAINER (69097-655-02)Marketed from Mar 23, 2022
69097-655-08	69097065508	120 TABLET in 1 CONTAINER (69097-655-08)Marketed from Mar 23, 2022

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Ritonavir film coatedSuffix: film coated
Generic name (nonproprietary): ritonavir 100 mg
Active ingredients: Ritonavir — 100 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Cipla USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 202573
Marketing start: Mar 23, 2022
Listing expires: Dec 31, 2026
Other FDA classes: Breast Cancer Resistance Protein Inhibitors (Mechanism)Cytochrome P450 1A2 Inducers (Mechanism)Cytochrome P450 2B6 Inducers (Mechanism)Cytochrome P450 2C19 Inducers (Mechanism)Cytochrome P450 2C9 Inducers (Mechanism)Cytochrome P450 2D6 Inhibitors (Mechanism)Cytochrome P450 3A Inducers (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)HIV Protease Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)UDP Glucuronosyltransferases Inducers (Mechanism)
Identifiers: Product ID 69097-655_eeb20aab-f62a-4d80-92d1-2d6b3e2a5758SPL ID eeb20aab-f62a-4d80-92d1-2d6b3e2a5758SPL set ID 4633c6ba-168d-426f-acae-7843e167743aRxCUI 900575UNII O3J8G9O825UPC 0369097655082, 0369097655020
Pharmacologic class: Cytochrome P450 3A Inhibitor; Protease Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N469097065502 followed by a unit qualifier and the quantity

Package 69097-0655-02. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.